
Researchers have found that education not only delays the early symptoms of dementia, but can also slow down the development of the disease.
The finding is a part of the thesis from the Sahlgrenska Academy at the University of Gothenburg, Sweden.
Advertisement
"This mechanism has previously been observed at a late stage of the disease, primarily in cases of Alzheimer's, which is a type of dementia," says Sindre Rolstad, researcher at the University of Gothenburg. "We wanted to investigate how education affected the disease in the early stages of dementia, known as mild cognitive impairment."
People with mild cognitive impairment can be affected by a reduction in their ability to think, such as reduced memory and a short attention span.
"We wanted to find out whether highly educated patients with mild cognitive impairment differed in terms of tolerance of the disease from patients with intermediate and low levels of education," says Rolstad.
By analysing the patients' spinal fluid, the researchers were able to examine whether there were signs of dementia in the brain.
"Highly educated patients with mild cognitive impairment who went on to develop dementia over the next two years had more signs of disease in their spinal fluid than those with intermediate and low levels of education," says Rolstad.
Despite having more disease in the brain, the highly educated patients showed the same symptoms of the disease as their less well educated counterparts. This means that patients with higher levels of education tolerate more disease in the brain.
The researchers also studied patients with mild cognitive impairment who did not go on to develop dementia over the next two years.
"We found that the highly educated patients who did not develop dementia during the course of the study showed signs of better nerve function than those with lower levels of education," says Rolstad. "This finding means that the highly educated not only tolerate more disease in the brain but also sustain less nerve damage during the early stages of the disease."
Source: ANI
Advertisement
"We wanted to find out whether highly educated patients with mild cognitive impairment differed in terms of tolerance of the disease from patients with intermediate and low levels of education," says Rolstad.
By analysing the patients' spinal fluid, the researchers were able to examine whether there were signs of dementia in the brain.
"Highly educated patients with mild cognitive impairment who went on to develop dementia over the next two years had more signs of disease in their spinal fluid than those with intermediate and low levels of education," says Rolstad.
Despite having more disease in the brain, the highly educated patients showed the same symptoms of the disease as their less well educated counterparts. This means that patients with higher levels of education tolerate more disease in the brain.
The researchers also studied patients with mild cognitive impairment who did not go on to develop dementia over the next two years.
"We found that the highly educated patients who did not develop dementia during the course of the study showed signs of better nerve function than those with lower levels of education," says Rolstad. "This finding means that the highly educated not only tolerate more disease in the brain but also sustain less nerve damage during the early stages of the disease."
Source: ANI
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest General Health News

In India, youth must be aware of the diseases linked to cigarette smoking and tobacco consumption, causing a form of healthcare emergency.

Direct coastal access may represent a viable route to public health promotion, but the relationships of coastal living are not strongest among lower-income groups.

New research by Tinnitus UK has found that over four million gardeners are putting their hearing capacity at risk this summer without using safety protection.

Mucus plugs could be targeted to help reduce fatalities from chronic obstructive pulmonary disease.

The development of reliable curative therapies for multiple sclerosis could significantly reduce the economic burden of the disease on patients and wider society.